Skip to main content
SpringerLink
Log in

Viral Hepatitis

  • Chapter
Sexually Transmitted Diseases

Part of the book series: Current Clinical Practice ((CCP))

  • 1101 Accesses

Abstract

Various forms of viral hepatitis have been identified as being sexually transmitted infections (STIs), whereas other forms are transmitted primarily via oralfecal routes. The most common forms of viral hepatitis are hepatitis A, B, and C. Hepatitis A virus (HAV) infection is most often a benign self-limiting disease; however, it can progress to fulminant liver failure. Fecal-oral transmission though contact with infectious sources in combination with poor hygiene or sanitation is the major route of HAV acquisition. Infection with hepatitis B virus (HB V) can be either acute and self-limited or can become chronic. HB V carriers are at increased risk of cirrhosis, hepatocellular carcinoma (HCC), and death from chronic liver disease. HB V can be transmitted perinatally, percutaneously, or across mucous membranes by sexual contact or by close person-to-person contact through open cuts and sores. Hepatitis C virus (HCV) is a blood-borne virus transmitted primarily by parenteral exposure to infected blood. The role of sexual exposure in transmission is minimal in HCV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004; 38(10 Suppl):S158–S168.

    Article  PubMed  Google Scholar 

  2. Shapiro CN, Coleman PJ, McQuillan GM, Alter MJ, Margolis HS. Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA. Vaccine 1992; 10:S59–S62.

    Article  PubMed  Google Scholar 

  3. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999; 48:1–37.

    Google Scholar 

  4. Centers for Disease Control and Prevention. Hepatitis awareness month—May 2006. MMWR Morb Mortal Wkly Rep 2006; 55:505.

    Google Scholar 

  5. Centers for Disease Control and Prevention. Summary of notifiable diseases—United States, 2004. MMWR Morb Mortal Wkly Rep 2006; 53(53): 1–79. Available from: http://www.cdc.gov/mmwr/summary.html. Accessed Nov. 24, 2006.

    Google Scholar 

  6. Centers for Disease Control and Prevention. Hepatitis surveillance report no. 61. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2004. Available from: http://www.cdc.gov/ncidod/diseases/hepatitis/resource/PDFs/hep_surveillance_61.pdf. Accessed Nov. 24, 2006.

    Google Scholar 

  7. World Health Organization. Hepatitis A. Department of communicable disease surveillance and response. Geneva: World Health Organization; 2001. Available from: http://www.who.int/csr/disease/hepatitis/whocdscsredc2007.html. Accessed Nov. 24, 2006.

    Google Scholar 

  8. Cuthbert JA. Hepatitis A: old and new. Clin Microbiol Rev 2001; 14:38–58.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2006. MMWR Recomm Rep 2006; 55(RR-11):69–78. Available from: http://www.cdc.gov/std/treatment/.Accessed Nov. 24, 2006.

    Google Scholar 

  10. Ross JDC, Ghanem M, Tariq A, Gilleran G, Winter AJ. Seroprevalence of hepatitis A immunity in male genitourinary medicine clinic attenders: a case control study of heterosexual and homosexual men. Sex Transm Infect 2002; 78:174–179.

    Article  CAS  PubMed  Google Scholar 

  11. Katz MH, Hsu L, Wong E, Liska S, Anderson L, Janssen RS. Seroprevalence of and risk factors for hepatitis A infection among young homosexual and bisexual men. J Infect Dis 1997; 175:1225–1229.

    Article  CAS  PubMed  Google Scholar 

  12. Corona R, Stroffolini T, Giglio A, et al. Lack of evidence for increased risk of hepatitis A infection in homosexual men. Epidemiol Infect 1999; 123:89–93.

    Article  CAS  PubMed  Google Scholar 

  13. Roy K, Howie H, Sweeney C, Parry J, Molyneaux P, Goldberg D, Taylor A. Hepatitis A virus and injecting drug misuse in Aberdeen, Scotland: a case-control study. J Viral Hepat 2004; 11: 277–282.

    Article  CAS  PubMed  Google Scholar 

  14. Glikson M, Galun E, Oren R, Tur-Kaspa R, Shouval D. Relapsing hepatitis A. Review of 14 cases and literature survey. Medicine (Baltimore). 1992; 71:14–23.

    CAS  Google Scholar 

  15. Gordon SC, Reddy KR, Schiff L, Schiff ER. Prolonged intrahepatic cholestasis secondary to acute hepatitis A. Ann Intern Med 1984; 101:635–637.

    Article  CAS  PubMed  Google Scholar 

  16. Kemmer NM, Miskovsky EP. Hepatitis A. Infect Dis Clin North Am 2000; 14:605–615.

    Article  CAS  PubMed  Google Scholar 

  17. O’Grady J. Management of acute and fulminant hepatitis A. Vaccine 1992; 10:S21–S23.

    Article  PubMed  Google Scholar 

  18. Vento S, Garofano T, Renzini C, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998; 338:286–290.

    Article  CAS  PubMed  Google Scholar 

  19. Liaw YF, Yang CY, Chu CM, Huang MJ. Appearance and persistence of hepatitis A IgM antibody in acute clinical hepatitis A observed in an outbreak. Infection 1986; 14:156–158.

    Article  CAS  PubMed  Google Scholar 

  20. Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996; 17:53–80 and Am J Infect Control 1996; 24:24–52.

    Article  CAS  PubMed  Google Scholar 

  21. Centers for Disease Control and Prevention. Guidelines for viral hepatitis surveillance and case management. Atlanta, GA; 2005. Available from: http://www.cdc.gov/ncidod/diseases/hepatitis/resource/PDFs/revised_GUIDELINES_formatted5.pdf. Accessed Nov. 24, 2006.

  22. Leikin E, Lysikiewicz A, Garry D, Tejani N. Intrauterine transmission of hepatitis A virus. Obstet Gynecol. 1996; 88:690–691.

    Article  CAS  PubMed  Google Scholar 

  23. American College of Obstetricians and Gynecologists. ACOG educational bulletin. Viral hepatitis in pregnancy. Number 248, July 1998 (replaces No. 174, November 1992). Int J Gynaecol Obstet 1998; 63:195–202.

    Google Scholar 

  24. Practice Committee of the American Society for Reproductive Medicine. Hepatitis and reproduction. Fertil Steril 2004; 82:1754–1764.

    Article  Google Scholar 

  25. Craig AS, Schaffner W. Prevention of hepatitis A with the hepatitis A vaccine. N Engl J Med 2004; 350:476–481.

    Article  CAS  PubMed  Google Scholar 

  26. Stokes J, Neefe JR. The prevention and attenuation of infectious hepatitis by gamma globulin; preliminary note. JAMA 1945; 127:144–145.

    Article  Google Scholar 

  27. Ellis EF, Henney CS. Adverse reactions following administration of human gamma globulin. J Allergy 1969; 43:45–54.

    Article  CAS  PubMed  Google Scholar 

  28. Diaz-Mitoma F, Law B, Parsons J. A combined vaccine against hepatitis A and B in children and adolescents. Pediatr Infect Dis J 1999; 18:109–114.

    Article  CAS  PubMed  Google Scholar 

  29. Clemens R, Safary A, Hepburn A, Roche C, Stanbury WJ, Andre FE. Clinical experience with an inactivated hepatitis A vaccine. J Infect Dis 1995; 171:S44–S49.

    Article  PubMed  Google Scholar 

  30. Ashur Y, Adler R, Rowe M, Shouval D. Comparison of immunogenicity of two hepatitis A vaccines—VAQTA and HAVRIX—in young adults. Vaccine 1999; 17:2290–2296.

    Article  CAS  PubMed  Google Scholar 

  31. McMahon BJ, Williams J, Bulkow L, et al. Immunogenicity of an inactivated hepatitis A vaccine in Alaska Native children and Native and non-Native adults. J Infect Dis 1995;171: 676–679.

    Article  CAS  PubMed  Google Scholar 

  32. Centers for Disease Control and Prevention. Hepatitis A. In: Atkinson W, Hamborsky J, Wolfe S, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases, 8th Ed. Washington, DC: Public Health Foundation; 2004, pp. 177–189.

    Google Scholar 

  33. Centers for Disease Control and Prevention. Recommended Adult Immunization Schedule, United States, October 2006-September 2007. Available from: http://www.cdc.gov/nip/recs/adult-schedule.htm. Accessed Nov. 24, 2006.

  34. Keeffe EB, Iwarson S, McMahon BJ, et al. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 1998; 27:881–886.

    Article  CAS  PubMed  Google Scholar 

  35. Neilsen GA, Bodsworth NJ, Watts N. Response to hepatitis A vaccination in human immunodeficiency virus-infected and-uninfected homosexual men. J Infect Dis 1997; 176:1064–1067.

    Article  CAS  PubMed  Google Scholar 

  36. Arslan M, Wiesner RH, Poterucha JJ, Zein NN. Safety and efficacy of hepatitis A vaccination in liver transplantation recipients. Transplantation 2001; 72:272–276.

    Article  CAS  PubMed  Google Scholar 

  37. Alter MJ, Mares A, Hadler SC, Maynard JE. The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis. Am J Epidemiol 1987; 125:133–139.

    CAS  PubMed  Google Scholar 

  38. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337:1733–1745.

    Article  CAS  PubMed  Google Scholar 

  39. Maynard JE. Hepatitis B: global importance and need for control. Vaccine 1990; 8:S18–S23.

    Article  PubMed  Google Scholar 

  40. Alter MJ, Hadler SC, Margolis HS, et al. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA 1990; 263:1218–1222.

    Article  CAS  PubMed  Google Scholar 

  41. Centers for Disease Control and Prevention (CDC). Incidence of acute hepatitis B—United States, 1990-2002. MMWR Morb Mortal Wkly Rep 2004; 52:1252–1254.

    PubMed  Google Scholar 

  42. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997; 336:1855–1859.

    Article  CAS  PubMed  Google Scholar 

  43. MacKellar DA, Valleroy LA, Secura GM, et al. Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men. Am J Public Health 2001; 91:965–971.

    Article  CAS  PubMed  Google Scholar 

  44. Papaevangelou GJ, Roumeliotou-Karayannis AJ, Contoyannis PC. The risk of nosocomial hepatitis A and B virus infections from patients under care without isolation precaution. J Med Virol 1981; 7:143–148.

    Article  CAS  PubMed  Google Scholar 

  45. Bond WW, Favero MS, Petersen NJ, Gravelle CR, Ebert JW, Maynard JE. Survival of hepatitis B virus after drying and storage for one week. Lancet 1981; 1:550–551.

    Article  CAS  PubMed  Google Scholar 

  46. Lok AS, McMahon BJ; Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Chronic hepatitis B: update of recommendations. Hepatology 2004; 39:857–861.

    Google Scholar 

  47. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 292:771–774.

    Article  CAS  PubMed  Google Scholar 

  48. Beasley RP, Hwang LY, Lin CC, Leu ML, Stevens CE, Szmuness W, Chen KP. Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis 1982; 146:198–204.

    Article  CAS  PubMed  Google Scholar 

  49. Coursaget P, Yvonnet B, Chotard J, et al. Ageand sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal). J Med Virol 1987; 22:1–5.

    Article  CAS  PubMed  Google Scholar 

  50. Tassopoulos NC, Papaevangelou GJ, Sjogren MH, Roumeliotou-Karayannis A, Gerin JL, Purcell RH. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology. 1987; 92:1844–1850.

    CAS  PubMed  Google Scholar 

  51. Yu MW, Hsu FC, Sheen IS, et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 1997; 145:1039–1047.

    Article  CAS  PubMed  Google Scholar 

  52. Liaw YF, Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 1988; 8:493–496.

    Article  CAS  PubMed  Google Scholar 

  53. Realdi G, Fattovich G, Hadziyannis S, et al. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP). J Hepatol 1994; 21:656–666.

    Article  CAS  PubMed  Google Scholar 

  54. Roudot-Thoraval F, Bastie A, Pawlotsky JM, Dhumeaux D. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Hepatology 1997; 26:485–490.

    Article  CAS  PubMed  Google Scholar 

  55. Housset C, Pol S, Carnot F, et al. Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus. Hepatology. 1992; 15:578–583.

    Article  CAS  PubMed  Google Scholar 

  56. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000—summary of a workshop. Gastroenterology. 2001; 120:1828–1853.

    Article  CAS  PubMed  Google Scholar 

  57. Chien RN, Liaw YF, Atkins M. Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group. Hepatology 1999; 30:770–774.

    Article  CAS  PubMed  Google Scholar 

  58. Perrillo RP, Lai CL, Liaw YF, et al. Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B. Hepatology 2002; 36:186–194.

    Article  CAS  PubMed  Google Scholar 

  59. Fattovich G, Brollo L, Giustina G, et al. Natural history and prognostic factors for chronic hepatitis type B. Gut 1991; 32:294–298.

    Article  CAS  PubMed  Google Scholar 

  60. de Jongh FE, Janssen HL, de Man RA, Hop WC, Schalm SW, van Blankenstein M. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology 1992; 103:1630–1635.

    PubMed  Google Scholar 

  61. Lau DT, Everhart J, Kleiner DE, et al. Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa. Gastroenterology 1997; 113:1660–1667.

    Article  CAS  PubMed  Google Scholar 

  62. Lok AS, McMahon BJ; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Chronic hepatitis B. Hepatology 2001; 34:1225–1241.

    Article  CAS  PubMed  Google Scholar 

  63. Villa E, Rubbiani L, Barchi T, et al. Susceptibility of chronic symptomless HBsAg carriers to ethanol-induced hepatic damage. Lancet 1982; 2:1243–1244.

    Article  CAS  PubMed  Google Scholar 

  64. Kim YI, Heathcote J, Wanless IR. The hepatitis B carrier state—a follow-up study of 100 consecutive cases. Clin Invest Med 1987; 10:383–387.

    CAS  PubMed  Google Scholar 

  65. Chevillotte G, Durbec JP, Gerolami A, Berthezene P, Bidart JM, Camatte R. Interaction between hepatitis B virus and alcohol consumption in liver cirrhosis. An epidemiologic study. Gastroenterology 1983; 85:141–145.

    CAS  PubMed  Google Scholar 

  66. Gall SA. Maternal immunization. Obstet Gynecol Clin North Am 2003; 30:623–636.

    Article  PubMed  Google Scholar 

  67. Poland GA, Jacobson RM. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 2004; 351:2832–2838.

    Article  CAS  PubMed  Google Scholar 

  68. Stevens CE, Toy PT, Tong MJ, et al. Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA 1985; 253:1740–1745.

    Article  CAS  PubMed  Google Scholar 

  69. Centers for Disease Control and Prevention. Hepatitis B. In: Atkinson W, Hamborsky J, Wolfe S, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases, 8th Ed. Washington DC: Public Health Foundation; 2004, pp. 191–212.

    Google Scholar 

  70. Hill JB, Sheffield JS, Kim MJ, Alexander JM, Sercely B, Wendel GD. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol 2002; 99: 1049–1052.

    Article  PubMed  Google Scholar 

  71. Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y.e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976; 294:746–749.

    Article  CAS  PubMed  Google Scholar 

  72. Hsu HM, Chen DS, Chuang CH, et al. Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers. JAMA 1988; 260:2231–2235.

    Article  CAS  PubMed  Google Scholar 

  73. Ascherio A, Zhang SM, Hernan MA, et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001; 344:327–332.

    Article  CAS  PubMed  Google Scholar 

  74. Confavreux C, Suissa S, Saddier P, Bourdes V, Vukusic S; Vaccines in Multiple Sclerosis Study Group. Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. N Engl J Med 2001; 344:319–326.

    Article  CAS  PubMed  Google Scholar 

  75. Kim WR. The burden of hepatitis C in the United States. Hepatology. 2002; 36:S30–S34.

    Article  PubMed  Google Scholar 

  76. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556–562.

    Article  CAS  PubMed  Google Scholar 

  77. Rosenberg J. Hep C Action Report. Medical Board of California; 1999, pp. 2–3.

    Google Scholar 

  78. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep 1998; 47:1–39.

    Google Scholar 

  79. Flamm SL. Chronic hepatitis C virus infection. JAMA 2003; 289:2413–2417.

    Article  PubMed  Google Scholar 

  80. Ohto H, Terazawa S, Sasaki N, et al. Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group. N Engl J Med 1994; 330:744–750.

    Article  CAS  PubMed  Google Scholar 

  81. Thomas DL, Villano SA, Riester KA, et al. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study. J Infect Dis 1998; 177:1480–1488.

    Article  CAS  PubMed  Google Scholar 

  82. Zanetti AR, Tanzi E, Newell ML. Mother-to-infant transmission of hepatitis C virus. J Hepatol 1999; 31:96–100.

    Article  PubMed  Google Scholar 

  83. Lin HH, Kao JH, Hsu HY, et al. Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers. J Pediatr 1995; 126:589–591.

    Article  CAS  PubMed  Google Scholar 

  84. Pekler VA, Robbins WA, Nyamathi A, Yashina TL, Leak B, Robins TA. Use of versant TMA and bDNA 3.0 assays to detect and quantify hepatitis C virus in semen. J Clin Lab Anal 2003; 17:264–270.

    Article  CAS  PubMed  Google Scholar 

  85. Belec L, Legoff J, Si-Mohamed A, et al. Cell-associated, non-replicating strand (+) hepatitis C virus-RNA shedding in cervicovaginal secretions from chronically HCV-infected women. J Clin Virol 2003; 27:247–251.

    Article  CAS  PubMed  Google Scholar 

  86. Thomas DL, Zenilman JM, Alter HJ, et al. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in B altimore—an analysis of 309 sex partnerships. J Infect Dis 1995; 171:768–775.

    Article  CAS  PubMed  Google Scholar 

  87. Vandelli C, Renzo F, Romano L, et al. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol 2004; 99:855–859.

    Article  PubMed  Google Scholar 

  88. Terrault NA. Sexual activity as a risk factor for hepatitis C. Hepatology 2002; 36:S99–S105.

    Article  PubMed  Google Scholar 

  89. Dienstag JL. Sexual and perinatal transmission of hepatitis C. Hepatology 1997; 26:66S–70S.

    Article  CAS  PubMed  Google Scholar 

  90. Hisada M, O’Brien TR, Rosenberg PS, Goedert JJ. Virus load and risk of heterosexual transmission of human immunodeficiency virus and hepatitis C virus by men with hemophilia. The Multicenter Hemophilia Cohort Study. J Infect Dis 2000; 181:1475–1478.

    Article  CAS  PubMed  Google Scholar 

  91. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36:S35–S46.

    Article  PubMed  Google Scholar 

  92. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992; 327:1899–1905.

    Article  CAS  PubMed  Google Scholar 

  93. Strader DB, Wright T, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39:1147–1171.

    Article  PubMed  Google Scholar 

  94. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002; 36:S21–S29.

    Article  PubMed  Google Scholar 

  95. Koff RS. Risks associated with hepatitis A and hepatitis B in patients with hepatitis C. J Clin Gastroenterol 2001; 33:20–26.

    Article  CAS  PubMed  Google Scholar 

  96. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis 1995; 15:5–14.

    Article  CAS  PubMed  Google Scholar 

  97. Gartner LM, Morton J, Lawrence RA, et al. Breastfeeding and the use of human milk. Pediatrics. 2005; 115:496–506.

    Article  PubMed  Google Scholar 

  98. Alter MJ, Kuhnert WL, Finelli L; Centers for Disease Control and Prevention. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003; 52:1–13, 15

    PubMed  Google Scholar 

  99. Taylor J, Negro F, Rizzetto M. Hepatitis delta virus: From structure to disease expression. Rev Med Virol 1992; 2:161–167.

    Article  Google Scholar 

  100. Tsega E, Krawczynski K, Hansson BG, Nordenfelt E. Hepatitis E virus infection in pregnancy in Ethiopia. Ethiop Med J 1993; 31:173–181.

    CAS  PubMed  Google Scholar 

  101. Alter MJ, Gallagher M, Morris TT, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. N Engl J Med 1997; 336:741–746.

    Article  CAS  PubMed  Google Scholar 

  102. Ramia S, Mokhbat J, Sibai A, Klayme S, Naman R; HIV Epidemiology Research Study Group. Exposure rates to hepatitis C and G virus infections among HIV-infected patients: evidence of efficient transmission of HGV by the sexual route. Int J STD AIDS 2004; 15:463–466.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. David Geffen School of Medicine at UCLA, USA

    Michelle L. Geller MD (Assistant Clinical Professor of Medicine, Section Head)

  2. Women’s Health Section, Division of General Internal Medicine, Department of Medicine, Harbor-UCLA Medical Center, Torrance, CA

    Michelle L. Geller MD (Assistant Clinical Professor of Medicine, Section Head)

  3. Department of Medicine, Harbor-UCLA Medical Center, Torrance, CA

    Jeremy R. Herman MD

Authors
  1. Michelle L. Geller MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeremy R. Herman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Harbor/UCLA Medical Center, Torrance, CA

    Anita L. Nelson MD

  2. Health Care Partners, Redondo Beach, CA

    JoAnn Woodward RNC, BSN, NP

  3. Harbor/UCLA Nurse Practitioner Program, Torrance, CA

    JoAnn Woodward RNC, BSN, NP

  4. National Association of Nurse Practitioners in Women’s Health, Washington, DC

    Susan Wysocki RNC, NP, FAANP (President and CEO) (President and CEO)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc.,Totowa NJ

About this chapter

Cite this chapter

Geller, M.L., Herman, J.R. (2006). Viral Hepatitis. In: Nelson, A.L., Woodward, J., Wysocki, S. (eds) Sexually Transmitted Diseases. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59745-040-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-040-9_4

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-58829-570-5

  • Online ISBN: 978-1-59745-040-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation